Search Orphan Drug Designations and Approvals
-
Generic Name: | dexrazoxane hydrochloride |
---|---|
Date Designated: | 08/19/2014 |
Orphan Designation: | Prevention of cardiomyopathy for chilren and adolescents 0 through 16 years of age treated with anthracyclines |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Satiscor, LLC 45 Marine Road Boston, Massachusetts 02127 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-